Literature DB >> 30898330

"I's" on the prize: A systematic review of individual differences in Contingency Management treatment response.

Sarah E Forster1, Dominick DePhilippis2, Steven D Forman3.   

Abstract

Contingency Management is an evidence-based treatment for substance use disorders with strong potential for measurement-based customization. Previous work has examined individual difference factors in Contingency Management treatment response of potential relevance to treatment targeting and adaptive implementation; however, a systematic review of such factors has not yet been conducted. Here, we summarize and evaluate the existing literature on patient-level predictors, mediators, and moderators of Contingency Management treatment response in stimulant and/or opioid using outpatients - clinical populations most frequently targeted in Contingency Management research and clinical practice. Our search strategy identified 648 unique, peer-reviewed publications, of which 39 met full inclusion criteria for the current review. These publications considered a variety of individual difference factors, including (1) motivation to change and substance use before and during treatment (8/39 publications), (2) substance use comorbidity and chronicity (8/39 publications), (3) psychiatric comorbidity and severity (8/39 publications), (4) medical, legal, and sociodemographic considerations (15/39 publications), and (5) cognitive-behavioral variables (1/39 publications). Contingency Management was generally associated with improved treatment outcomes (e.g., longer periods of continuous abstinence, better retention), regardless of individual difference factors; however, specific patient-level characteristics were associated with either an enhanced (e.g., more previous treatment attempts, history of sexual abuse, diagnosis of antisocial personality disorder) or diminished (e.g., complex post-traumatic stress symptoms, pretreatment benzodiazepine use) response to Contingency Management. Overall, the current literature is limited but existing evidence generally supports greater benefits of Contingency Management in patients who would otherwise have a poorer prognosis in standard outpatient care. It was also identified that the majority of previous work represents a posteriori analysis of pre-existing clinical samples and has therefore rarely considered pre-specified, hypothesis-driven individual difference factors. We therefore additionally highlight patient-level factors that are currently understudied, as well as promising future directions for measurement-based treatment adaptations that may directly respond to patient traits and states to improve Contingency Management effectiveness across individuals and over time. Published by Elsevier Inc.

Entities:  

Keywords:  Behavioral interventions; Contingency Management; Individual differences; Measurement-based care; Motivational incentives; Substance use disorders

Year:  2019        PMID: 30898330     DOI: 10.1016/j.jsat.2019.03.001

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  7 in total

1.  Barriers and Facilitators That Influence Providers' Ability to Educate, Monitor, and Treat Substance Use in First-Episode Psychosis Programs Using the Theoretical Domains Framework.

Authors:  Oladunni Oluwoye; Elizabeth Fraser
Journal:  Qual Health Res       Date:  2021-02-16

2.  Spending money to make change: Association of methamphetamine abstinence and voucher spending among contingency management pilot participants in South Africa.

Authors:  Tamar Krishnamurti; Kimberly Ling Murtaugh; Lara Van Nunen; Alexander L Davis; Jonathan Ipser; Steven Shoptaw
Journal:  J Subst Abuse Treat       Date:  2020-01-25

Review 3.  Meta-Analysis on the Effect of Contingency Management for Patients with Both Psychotic Disorders and Substance Use Disorders.

Authors:  Marianne Destoop; Lise Docx; Manuel Morrens; Geert Dom
Journal:  J Clin Med       Date:  2021-02-06       Impact factor: 4.241

4.  "Setting people up for success and then failure" - health care and service providers' experiences of using prize-based contingency management.

Authors:  Marilou Gagnon; Adrian Guta; Alayna Payne
Journal:  Subst Abuse Treat Prev Policy       Date:  2020-09-14

Review 5.  Misalignment of Stakeholder Incentives in the Opioid Crisis.

Authors:  Alireza Boloori; Bengt B Arnetz; Frederi Viens; Taps Maiti; Judith E Arnetz
Journal:  Int J Environ Res Public Health       Date:  2020-10-16       Impact factor: 3.390

Review 6.  What are the ethical implications of using prize-based contingency management in substance use? A scoping review.

Authors:  Marilou Gagnon; Alayna Payne; Adrian Guta
Journal:  Harm Reduct J       Date:  2021-08-04

7.  Electrophysiological predictors and indicators of contingency management treatment response: Rationale and design for the ways of rewarding abstinence project (WRAP).

Authors:  Sarah E Forster; Steven D Forman; Naomi N Gancz; Greg J Siegle; Michael Walsh Dickey; Stuart R Steinhauer
Journal:  Contemp Clin Trials Commun       Date:  2021-06-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.